When the pandemic interfered with his own research, David Aminoff, Ph.D., D.Sc., wrote up a summary of his most recent biomarker work to serve as a resource for future researchers. His letter, which describes "the use of erythrocytes in a flow cytometer to identify biomarkers for multiple diseases and pathogens, including Alzheimer's disease (AD), and for hemodialysis patients before and after dialysis," has now been published in Cytometry Part B: Clinical Cytometry. Kudos to David for his perseverance and his dedication to scientific progress!
October 1, 2021
Professor emeritus David Aminoff has published a letter in Clinical Cytometry
The use of erythrocytes as biomarkers with a timeline